Compared to normal brain tissues, GBM tumors exhibit significant up-regulation of enzymes involved in glucose metabolism and FAO pathways,72 consequently, simultaneously inhibiting both pathways can effectively suppress GBM tumor growth,73 and either CPT1 inhibitors treatment alone or in combination with other chemotherapy drugs can enhance the anti-tumor effect.74 This evidence concerns the gene CPT1A and glioblastoma.